Joint Formulary & PAD

Oseltamivir phosphate - Influenza

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Oral solution
  • Oral suspension
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

recommended for  treatment of influenza in adults and children meeting the criteria set out in NICE TA 168 and for prophylaxis of influenza in adults and children meeting the criteria set out in NICE TA 158

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Oseltamivir phosphate
Indication :
Influenza
Group Name :
Keywords :
prophylaxis
Brand Names Include :
Tamiflu
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Oseltamivir phosphate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Influenza.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.